Hegea Bio
Hangzhou
About Hegea Bio
Hegeia Biotechnology is a company that focused on the research and development of siRNA, tiny nucleic acid attached delivery medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $13.8M
- Funding stage: M&A
- Last round: Series A (Sep 2024)
- Website: hygieiapharma.com
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/hegea-bio-55069 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.